2024 annual financial data
ALX Oncology Holdings 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -142,467,000 USD and net income was -134,850,000 USD.
Operating cash flow was -121,912,000 USD.
Get free ALX Oncology Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -142,467,000 USD
- Net income
- -134,850,000 USD
- Operating cash flow
- -121,912,000 USD